CD274 and neoplasm: Thus, the evaluation of tumour microenvironment can provide insights into prognosis and immunotherapeutic options (anti-PD-L1 treatment, combination with radiotherapy, vaccines etc.)in accordance with the identified ITs I–IV [176,177].